Inovio PharmaceuticalsINO
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$1.75avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Inovio Pharmaceuticals Inc. (INO) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Byrne Asset Management LLC ($7).
- Company
- Inovio Pharmaceuticals Inc.
- CUSIP
- 45773H102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Byrne Asset Management LLC | 0.00% | No change | 4 | $7 |
"% of holder's portfolio" is INO's weight in each manager's 13F, not the share of Inovio Pharmaceuticals Inc. the manager owns.